長青集團(002616.SZ):“新野長青生物質熱電聯產項目”完成了試運行
格隆匯1月5日丨長青集團(002616.SZ)公佈,公司投資建設的“新野長青生物質熱電聯產項目”近期完成了試運行,於2022年1月1日基本滿足長期穩定運行的條件。
該項目建設地點位於新野縣產業集聚區西區西南部,建設規模為1×140T/h生物質鍋爐和1×30MW抽凝式汽輪發電機組。該工程概算投資額為3.68億元。
該項目主要利用黃色秸稈做為燃料,可減少火力發電對環境造成的污染,有助於改善環境,並提高用能效率,最大限度地發揮環保效益。該工程不設灰渣場,灰渣直接還田或綜合利用,具有一定的環境效益和經濟效益。
該項目的實施預計將對公司2022年經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.